NCT05763173Completed
Evaluation of Lung Metastases Based on Ultrashort Echo Time MRI
The Diagnostic Value of Lung Ultrashort Echo Time MRI for Potential Lung Metastases in Children With Hepatoblastoma
Source: ClinicalTrials.gov · Last updated 18 Apr 2024
Brief summary (registry, in English)
Analyze the diagnostic efficiency (including performance, diameter, and location of nodules) of UTE-MRI in lung metastases of hepatoblastoma with chest CT as gold standard
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 65 (actual)
- First submitted
- 28 Feb 2023
- Start date
- 1 Jan 2023
- Primary completion date
- 29 Feb 2024
- Lead sponsor
- RenJi Hospital
- Diseases
- Lung cancer, Childhood cancers
- NCT number
- NCT05763173
What you commit to
- Study type: Observational
- Participants enrolled: 65
- From 1 Jan 2023 to the primary completion date, 29 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Children after surgery for hepatoblastoma
- There is a concomitant medical condition (e.g. poorly controlled hypertension, severe diabetes, neurological or psychiatric illness, etc.) or any other condition that would seriously endangers the subject's safety, may confuse the study results, or may interfere with the subject's completion of the study according to the investigator's judgment.
Other illness
- MRI contraindications (including but not limited to: contrast medium allergy; Claustrophobia;Metal implants;chronic kidney disease≥stage 3 (glomerular filtration rate \< 60 mL min-1 (1.73 m2)-1))
Age
- Patients with hepatoblastoma aged 14 years and above
Other
- Application of any contrast medium within 24 h before the MRI and/or CT examinations
Who the study is looking for
- Children diagnosed as hepatoblastoma (including treated with neoadjuvant chemotherapy but not surgery)
- Recent chest CT scan (within 14 days)
- No MRI contraindications
- The guardian of the children are willing to undergo the examination after full communication and informed consent
Age in the registry: - to 14 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiaotong University Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.